New Drug Effective For Prostate Cancer Being Tried In Breast Cancer

[Lani]

Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer

http://www.drugs.com/clinical_trials/data-presented-aacr-annual-meeting-shows-bavituximab-equivalent-plus-docetaxel-reduces-tumor-growth-3920.html